MENLO PARK

Sight Sciences to Report Third Quarter 2023 Financial Results on November 7, 2023

Retrieved on: 
Tuesday, October 24, 2023
News, Webcast, Communications satellite, Broadcasting

MENLO PARK, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced it will report financial results for the third quarter ended September 30, 2023, after the market close on Tuesday, November 7, 2023.

Key Points: 
  • MENLO PARK, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced it will report financial results for the third quarter ended September 30, 2023, after the market close on Tuesday, November 7, 2023.
  • The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.sightsciences.com , on the Investors page in the News & Events section.
  • The webcast will be available for replay for at least 90 days after the event.

Sight Sciences to Host SAHARA 6 Month RCT Results Reception at the American Academy of Ophthalmology 2023

Retrieved on: 
Thursday, October 19, 2023
Q&A, RCT

MENLO PARK, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced they will be hosting a TearCare SAHARA Six Month RCT Results reception in San Francisco, CA on Friday, November 3, 2023 from 5:00 to 7:00 pm PT.

Key Points: 
  • MENLO PARK, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced they will be hosting a TearCare SAHARA Six Month RCT Results reception in San Francisco, CA on Friday, November 3, 2023 from 5:00 to 7:00 pm PT.
  • A live and archived webcast of the event will be available on Sight Sciences’ investor relations website at https://investors.sightsciences.com .
  • Please note that Q&A will be conducted live, in-person only following the formal presentation.
  • Please email [email protected] by October 30, 2023 to request an invitation.

Sight Sciences Announces Presentation of Successful Phase I Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease at the American Academy of Optometry Annual Meeting

Retrieved on: 
Thursday, October 12, 2023
Health, Telecanthus, Inflammation, American Academy, Test management, Gland, Randomized controlled trial, Principal, Clinical trial, Patient, RCT, OSDI, Keratoconjunctivitis, Medical imaging, Pharmaceutical industry, Ciclosporin

These results were presented today at the American Academy of Optometry’s annual meeting in New Orleans.

Key Points: 
  • These results were presented today at the American Academy of Optometry’s annual meeting in New Orleans.
  • “Pharmaceutical intervention with Restasis has been the hallmark of dry eye treatment since its introduction.
  • SAHARA included 345 subjects at 25 sites in 14 states randomized 1:1 between TearCare and Restasis groups.
  • TearCare and Restasis also delivered comparable statistically significant clinical improvements in OSDI scores, Symptoms Assessment in Dry Eye (“SANDE”) scores, and Eye Dryness Scores (“EDS”), patient reported outcomes to subjectively assess dry eye severity.

Exponent to Announce Third Quarter of Fiscal Year 2023 Results and Host Quarterly Conference Call on October 26, 2023

Retrieved on: 
Thursday, October 5, 2023
Webcast, EXPO, Exponentiation, Cryptocurrency, Management

MENLO PARK, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report third quarter of fiscal year 2023 financial results for the period ended September 29, 2023 following the close of the market on Thursday, October 26, 2023.

Key Points: 
  • MENLO PARK, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report third quarter of fiscal year 2023 financial results for the period ended September 29, 2023 following the close of the market on Thursday, October 26, 2023.
  • On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m.
  • ET (1:30 p.m. PT) to discuss the Company’s business and financial results.

Robinhood Markets, Inc. to Announce Third Quarter 2023 Results on November 7, 2023

Retrieved on: 
Thursday, October 5, 2023
Q&A, Robin Hood, Video game

MENLO PARK, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Today, Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) announced that it will release its third quarter 2023 financial results on Tuesday, November 7, 2023, after market close.

Key Points: 
  • MENLO PARK, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Today, Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) announced that it will release its third quarter 2023 financial results on Tuesday, November 7, 2023, after market close.
  • Robinhood shareholders can submit and upvote questions for management using the Q&A platform developed by Say Technologies ahead of Robinhood’s third quarter 2023 earnings call.
  • The Q&A platform will be open for question submission starting Tuesday, October 31, 2023, at 2:00 PM PT / 5:00 PM ET.
  • Shareholders will be able to submit and upvote questions until Monday, November 6, 2023, at 2:00 PM PT / 5:00 PM ET.

Sight Sciences Announces New, Large-Scale MIGS Data from 41st Congress of ESCRS Demonstrating TCOR™ Using OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma

Retrieved on: 
Tuesday, October 3, 2023
Glaucoma, IOP, University, IRIS, Princess Alexandra Eye Pavilion, MIGS, Intraocular pressure, Medicare, Telecanthus, Patient, Data, Standard of care, University of Edinburgh, OMNI, Nursing

The value of TCOR is that it offers sustained IOP-control.

Key Points: 
  • The value of TCOR is that it offers sustained IOP-control.
  • Independent data from the IRIS Registry is valuable and we believe it will inform surgeons’ decision-making when considering the best treatment option for their glaucoma patients.
  • We look forward to sharing this analysis and educating Medicare and healthcare insurers about the TCOR comprehensive MIGS procedure enabled by OMNI technology.
  • “Our mission at Sight Sciences is to elevate the standard of care for patients by furnishing eye doctors with the best technology to improve patient outcomes.

LifeMoves Welcomes New Board Members

Retrieved on: 
Thursday, September 28, 2023

These new Board members are committed to LifeMoves' unwavering mission.

Key Points: 
  • These new Board members are committed to LifeMoves' unwavering mission.
  • “I’m honored to welcome these remarkable individuals to our Board of Directors,” said Aubrey Merriman, Chief Executive Officer of LifeMoves.
  • It is especially important that our Board membership reflects the communities and individuals that we serve.
  • "With the addition of these accomplished Board members, we're bolstering our capacity to expand impactful initiatives," stated Patrick Heron, LifeMoves Board Chair.

Joshu Unveils Underwriter Desk 2.0

Retrieved on: 
Wednesday, September 20, 2023
Insurance, GRAS, Workflow, Policy, Language, Radius, Risk, Artificial intelligence, Fintech, PDF, Hand, Reinsurance, Microsoft Excel, Jōshū

As part of the Joshu Platform , Underwriter Desk delivers a digital workflow that caters to improving the underwriting process.

Key Points: 
  • As part of the Joshu Platform , Underwriter Desk delivers a digital workflow that caters to improving the underwriting process.
  • The new features inherent to Underwriter Desk 2.0 expands capabilities to help underwriters better assess risk and improve underwriting quality.
  • In the competitive specialty insurance market, Underwriter Desk 2.0 speeds the underwriting process for insurance products requiring deep risk analysis and bespoke policy assembly.
  • Dynamic Documentation Integration: Underwriter Desk 2.0 empowers underwriters to add or remove policy forms while reviewing submissions and preparing quotes and binders.

Motorq Joins Forces with Leading OEM to Revolutionize Fleet Analytics and Connected Vehicle Insights

Retrieved on: 
Monday, September 18, 2023
Partnership, EV, Mercedes-Benz, API, EVS, SAN, OEM, Health, Safety, Car dealership, Fleet

By joining forces with Mercedes-Benz Connectivity Services, Motorq can further empower fleets with cutting-edge insights in areas such as driver safety, vehicle health, electrification strategies, and beyond.

Key Points: 
  • By joining forces with Mercedes-Benz Connectivity Services, Motorq can further empower fleets with cutting-edge insights in areas such as driver safety, vehicle health, electrification strategies, and beyond.
  • “At Motorq, we’re developing a higher caliber of analytics for fleets of all sizes,” said Arun Rajagopalan, CEO and Co-Founder of Motorq.
  • “By directly plugging Mercedes-Benz vehicle data into Motorq’s multi-layered vehicle insights, we can create state-of-the-art access to vehicle information.
  • Mercedes-Benz Connectivity Services’ strong dedication to secure vehicle insights paired with Motorq’s focus on solving paramount challenges for fleets opens doors for anyone demanding more from their vehicle analytics.

Robinhood Markets, Inc. Reports August 2023 Operating Data

Retrieved on: 
Wednesday, September 13, 2023
Crypto, Net, Robinhood Markets, MAU, NCFA, AUC, Cryptocurrency

MENLO PARK, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported selected monthly operating data for August 2023:

Key Points: 
  • MENLO PARK, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported selected monthly operating data for August 2023:
    Net Cumulative Funded Accounts (NCFA) at the end of August were 23.2 million, up approximately 30 thousand from July 2023(1).
  • Assets Under Custody (AUC) at the end of August were $89.7 billion, down 5% from July 2023.
  • Net Deposits were $1.6 billion in August, translating to a 20% annualized growth rate relative to July 2023 AUC.
  • Cash Sweep Balances at the end of August were $13.3 billion, up $0.6 billion (5%) from the end of July 2023.